Today, Creative Planning invests in Clorox Co. (CLX) Shares

Today, Creative Planning invests in Clorox Co. (CLX) Shares
Creative Planning increased its stake in shares of Clorox Co. (NYSE:CLX) by 17.6% during the third quarter, Holdings Channel reports. The firm owned 15,578 shares of the company’s stock after buying an additional 2,326 shares during the period. Creative Planning’s holdings in Clorox were worth $1,950,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently modified their holdings of the stock. Checchi Capital Advisers LLC raised its stake in shares of Clorox by 1.0% in the second quarter. Checchi Capital Advisers LLC now owns 820 shares of the company’s stock valued at $113,000 after buying an additional 8 shares during the period. Feltz Wealth PLAN Inc. bought a new stake in shares of Clorox during the second quarter valued at about $114,000. Valley National Advisers Inc. raised its stake in shares of Clorox by 0.6% in the second quarter. Valley National Advisers Inc. now owns 845 shares of the company’s stock valued at $117,000 after buying an additional 5 shares during the period. Blue Chip Partners Inc. raised its stake in shares of Clorox by 7.1% in the second quarter. Blue Chip Partners Inc. now owns 890 shares of the company’s stock valued at $123,000 after buying an additional 59 shares during the period. Finally, Assetmark Inc. raised its stake in shares of Clorox by 113.2% in the second quarter. Assetmark Inc. now owns 968 shares of the company’s stock valued at $134,000 after buying an additional 514 shares during the period. Hedge funds and other institutional investors own 69.90% of the company’s stock.

Shares of Clorox Co. (NYSE:CLX) traded up 1.51% during trading on Friday, reaching $117.22. The company had a trading volume of 448,683 shares. The company has a market capitalization of $15.09 billion, a P/E ratio of 23.60 and a beta of 0.36. Clorox Co. has a 52-week low of $111.24 and a 52-week high of $140.47. The firm has a 50-day moving average price of $117.63 and a 200-day moving average price of $127.59.

Clorox (NYSE:CLX) last announced its earnings results on Wednesday, November 2nd. The company reported $1.36 EPS for the quarter, missing the consensus estimate of $1.42 by $0.06. The company had revenue of $1.44 billion for the quarter, compared to analysts’ expectations of $1.24 billion. Clorox had a net margin of 11.27% and a return on equity of 250.82%. The business’s quarterly revenue was up 3.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.32 earnings per share. On average, analysts predict that Clorox Co. will post $5.32 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 10th. Shareholders of record on Wednesday, January 25th will be issued a dividend of $0.80 per share. The ex-dividend date of this dividend is Monday, January 23rd. This represents a $3.20 annualized dividend and a yield of 2.73%. Clorox’s dividend payout ratio is presently 64.26%.

CLX has been the topic of several research analyst reports. Zacks Investment Research upgraded shares of Clorox from a “hold” rating to a “buy” rating and set a $148.00 price objective on the stock in a report on Monday, August 8th. Atlantic Securities upgraded shares of Clorox from a “hold” rating to a “buy” rating and set a $144.00 price objective on the stock in a report on Friday, September 16th. Jefferies Group restated a “hold” rating on shares of Clorox in a report on Wednesday, August 3rd. Wells Fargo & Co. reiterated a “market perform” rating on shares of Clorox in a research note on Tuesday, November 15th. Finally, B. Riley reiterated a “neutral” rating and set a $109.00 price target on shares of Clorox in a research note on Tuesday, August 9th. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $127.30.

In other news, EVP Laura Stein sold 38,882 shares of the business’s stock in a transaction that occurred on Friday, September 2nd. The stock was sold at an average price of $131.69, for a total value of $5,120,370.58. Following the completion of the sale, the executive vice president now directly owns 48,501 shares in the company, valued at approximately $6,387,096.69. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Jon M. Balousek sold 5,136 shares of the business’s stock in a transaction that occurred on Monday, August 29th. The shares were sold at an average price of $131.14, for a total value of $673,535.04. Following the completion of the sale, the senior vice president now owns 15,384 shares of the company’s stock, valued at $2,017,457.76. The disclosure for this sale can be found here. Company insiders own 0.74% of the company’s stock.

About Clorox

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Related posts

Leave a Comment